Skip to main content

and
  1. No Access

    Article

    Adjuvant systemic therapy in early breast cancer: impact of guideline changes and clinicopathological factors associated with nonadherence at a nation-wide level

    Over recent years, adjuvant systemic treatment guidelines (AST) for early-stage breast cancer have changed considerably. We aimed to assess the impact of these guideline changes on the administration of AST in...

    A. M. F. Verschoor, A. Kuijer, J. Verloop in Breast Cancer Research and Treatment (2016)